Glimipack MV 1mg/500mg/0.2mg Tablet
Marketer
Koye Pharmaceuticals Pvt ltd
Salt Composition
Glimepiride (1mg) + Metformin (500mg) + Voglibose (0.2mg)
Overview Glimipack MV 1mg/500mg/0.2mg Tablet
Diabetol Trio 1mg/500mg/0.2mg tablets are classified as antidiabetic medications, a combination therapy for adult type 2 diabetes. This formulation helps regulate blood glucose in diabetic patients. Diabetol Trio should be ingested with food, consistently at the same time daily for optimal efficacy. Dosage is determined by your physician and may be adjusted based on your blood sugar response. Continuous use is crucial; discontinuation without medical consultation risks elevated blood sugar, potentially leading to kidney complications, vision impairment, neuropathy, and limb loss. Remember, this medication is one component of a comprehensive diabetes management plan encompassing a balanced diet, regular physical activity, and weight management as directed by your doctor. Lifestyle significantly impacts diabetes control. Hypoglycemia (low blood sugar) is a prevalent side effect, characterized by sweating, dizziness, headache, and tremors. Learn to recognize these symptoms and manage them accordingly; maintain regular meals and carry a quick-acting glucose source, such as candy or juice. Alcohol consumption elevates hypoglycemia risk and should be limited. Additional potential side effects include altered taste, nausea, diarrhea, abdominal pain, headache, edema, blurred vision, bone fractures, and upper respiratory infections. Weight gain may occur. This medication is contraindicated in type 1 diabetes, diabetic ketoacidosis, and severe hepatic or renal impairment. Inform your physician of any pre-existing heart conditions before commencing treatment. Pregnant or lactating individuals should seek medical advice prior to use. Regular blood glucose monitoring and periodic blood tests (blood cell counts and liver function) are recommended by your doctor.
Primary Ingredients of Glimipack MV 1mg/500mg/0.2mg Tablet
The provided text is "undefined," which lacks meaning and cannot be rephrased.
Uses of Glimipack MV 1mg/500mg/0.2mg Tablet
Managing type 2 diabetes
Major Benefits of Glimipack MV 1mg/500mg/0.2mg Tablet:
Consume this medication precisely as your physician directs, adhering to both the prescribed dosage and treatment length. Ingest the tablet whole; avoid chewing, crushing, or fracturing it. Administer Glimipack MV 1mg/500mg/0.2mg Tablet on an empty stomach.
Common Side effects of Glimipack MV 1mg/500mg/0.2mg Tablet:
- Nausea
- Diarrhea
- Abdominal pain
- Hypoglycemia (low blood glucose level)
- Loss of appetite
How to use Glimipack MV 1mg/500mg/0.2mg Tablet:
Consume this medication precisely as prescribed by your physician, adhering to the specified dosage and treatment period. Ingest the entire tablet without chewing, crushing, or breaking it. Glimipack MV 1mg/500mg/0.2mg tablets should be administered on an empty stomach.
How Glimipack MV 1mg/500mg/0.2mg Tablet works:
Glimipack MV tablets (1mg/500mg/0.2mg) contain a triple-drug formulation for diabetes management.
SAFETY ADVICE
AlcoholUNSAFE
Combining Glimipack MV 1mg/500mg/0.2mg tablets with alcohol is inadvisable.
PregnancyCONSULT YOUR DOCTOR
The use of Glimipack MV 1mg/500mg/0.2mg tablets during pregnancy may pose risks. While human data is scarce, animal research indicates potential harm to a fetus. A physician will assess the advantages against possible dangers prior to prescribing this medication. Seek medical advice before taking this drug.
Breast feedingCONSULT YOUR DOCTOR
The use of Glimipack MV 1mg/500mg/0.2mg tablets while breastfeeding is likely inadvisable. Preliminary evidence from human studies indicates potential transfer of the medication into breast milk, posing a risk to the infant.
DrivingCAUTION
Driving may be impaired by excessively low or high blood sugar levels. Refrain from driving if you experience these conditions.
KidneyUNSAFE
Patients with kidney disease should likely avoid Glimipack MV 1mg/500mg/0.2mg Tablets due to potential safety concerns. Medical advice is necessary. Furthermore, its use is discouraged in individuals with severely impaired kidney function.
LiverCAUTION
Patients with liver impairment should use Glimipack MV 1mg/500mg/0.2mg tablets cautiously, potentially requiring dosage modification. Medical advice is essential. For those with mild to moderate liver disease, a low initial dose is typically recommended; however, its use is contraindicated in individuals with severe hepatic dysfunction.
What if you forget to take Glimipack MV 1mg/500mg/0.2mg Tablet :
Should you forget to take your Glimipack MV 1mg/500mg/0.2mg Tablet, administer it immediately. Nevertheless, if your next scheduled dose is imminent, omit the missed dose and resume your usual dosing pattern. Avoid taking a double dose.
Facts to Know About Glimipack MV 1mg/500mg/0.2mg Tablet
| Label | Value |
|---|---|
| Developing Habits | No. |
| Treatment Category | Diabetes Treatment |
3,018 People bought this recently